Journal
MOLECULAR DIVERSITY
Volume 26, Issue 1, Pages 157-169Publisher
SPRINGER
DOI: 10.1007/s11030-020-10171-6
Keywords
SARS-CoV-2; Spike protein; Peptide aptamer; Molecular docking; Molecular dynamic simulation
Categories
Funding
- Council of Scientific and Industrial Research-Senior Research Fellowship
- Indian Council of Medical Research-Senior Research Fellowship
Ask authors/readers for more resources
Peptide aptamers are short synthetic peptide molecules that bind to specific target proteins with high affinity. Research is currently focused on designing peptide aptamers targeting the spike protein of SARS-CoV-2, with molecular modeling and dynamic simulations used to validate their stability and binding to the virus.
Short synthetic peptide molecules which bind to a specific target protein with a high affinity to exert its function are known as peptide aptamers. The high specificity of aptamers with small-molecule targets (metal ions, dyes and theophylline; ATP) is within 1 pM and 1 mu M range, whereas with the proteins (thrombin, CD4 and antibodies) it is in the nanomolar range (which is equivalent to monoclonal antibodies). The recently identified coronavirus (SARS-CoV-2) genome encodes for various proteins, such as envelope, membrane, nucleocapsid, and spike protein. Among these, the protein necessary for the virus to enter inside the host cell is spike protein. The work focuses on designing peptide aptamer targeting the spike receptor-binding domain of SARS-CoV-2. The peptide aptamer has been designed by using bacterial Thioredoxin A as the scaffold protein and an 18-residue-long peptide. The tertiary structure of the peptide aptamer is modeled and docked to spike receptor-binding domain of SARS CoV2. Molecular dynamic simulation has been done to check the stability of the aptamer and receptor-binding domain complex. It was observed that the aptamer binds to spike receptor-binding domain of SARS-CoV-2 in a similar pattern as that of ACE2. The aptamer-receptor-binding domain complex was found to be stable in a 100 ns molecular dynamic simulation. The aptamer is also predicted to be non-antigenic, non-allergenic, non-hemolytic, non-inflammatory, water-soluble with high affinity toward ACE2 than serum albumin. Thus, peptide aptamer can be a novel approach for the therapeutic treatment for SARS-CoV-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available